Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (791-800 of 910) with videos related to

Pageof 91
Sort By:
Pharmacogenomics|August 1, 2015
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in childrenHenk Visscher, S Rod Rassekh, George S Sandor, et al.
Neurobiology of Disease|May 15, 2020
Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's diseaseStefan Bartl, Abid Oueslati, Amber L Southwell, et al.
Human Molecular Genetics|July 29, 2016
Pridopidine activates neuroprotective pathways impaired in Huntington DiseaseMichal Geva, Rebecca Kusko, Holly Soares, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2009
Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of diseaseRona K Graham, Mahmoud A Pouladi, Prasad Joshi, et al.
Human Molecular Genetics|February 1, 1997
Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.
Human Molecular Genetics|March 6, 2015
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicityVirginia B Mattis, Colton Tom, Sergey Akimov, et al.
Brain : a Journal of Neurology|May 19, 2016
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic studyMario Masellis, Shannon Collinson, Natalie Freeman, et al.
American Journal of Hypertension|February 10, 2012
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic ratsTadashi Sofue, Hideyasu Kiyomoto, Hiroyuki Kobori, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2015
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female MiceVincent G DeMarco, Javad Habibi, Guanghong Jia, et al.
Journal of Environmental Quality|August 3, 2022
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central PennsylvaniaKathryn R Hayden, Matthew Jones, Kyle R Elkin, et al.
Pageof 91

Showing results (791-800 of 910) with videos related to

Sort By:
Pageof 91
Pharmacogenomics|August 1, 2015
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in childrenHenk Visscher, S Rod Rassekh, George S Sandor, et al.
Neurobiology of Disease|May 15, 2020
Inhibiting cellular uptake of mutant huntingtin using a monoclonal antibody: Implications for the treatment of Huntington's diseaseStefan Bartl, Abid Oueslati, Amber L Southwell, et al.
Human Molecular Genetics|July 29, 2016
Pridopidine activates neuroprotective pathways impaired in Huntington DiseaseMichal Geva, Rebecca Kusko, Holly Soares, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2009
Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of diseaseRona K Graham, Mahmoud A Pouladi, Prasad Joshi, et al.
Human Molecular Genetics|February 1, 1997
Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analysesS S Chong, E Almqvist, H Telenius, et al.
Human Molecular Genetics|March 6, 2015
HD iPSC-derived neural progenitors accumulate in culture and are susceptible to BDNF withdrawal due to glutamate toxicityVirginia B Mattis, Colton Tom, Sergey Akimov, et al.
Brain : a Journal of Neurology|May 19, 2016
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic studyMario Masellis, Shannon Collinson, Natalie Freeman, et al.
American Journal of Hypertension|February 10, 2012
Early treatment with olmesartan prevents juxtamedullary glomerular podocyte injury and the onset of microalbuminuria in type 2 diabetic ratsTadashi Sofue, Hideyasu Kiyomoto, Hiroyuki Kobori, et al.
Hypertension (Dallas, Tex. : 1979)|May 28, 2015
Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female MiceVincent G DeMarco, Javad Habibi, Guanghong Jia, et al.
Journal of Environmental Quality|August 3, 2022
Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central PennsylvaniaKathryn R Hayden, Matthew Jones, Kyle R Elkin, et al.
Pageof 91